AbCellera appoints Andrew Lo as independent director; John Hamer resigns

AbCellera Biologics Inc.

Andrew W. Lo, Ph.D., appointed as independent director effective December 7, 2021.
Lo will serve on Audit and Compensation Committees; he is an MIT professor and TIME 100 honoree.
John Hamer, Ph.D., managing partner at DCVC Bio, resigned from the board effective immediately.
Hamer had served on the board since 2018, including on Audit and Compensation Committees.
CEO Carl Hansen thanked Hamer for his guidance and welcomed Lo for his financial/biomedical expertise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.